Interested parties hope to see reauthorization of the Food and Drug Administration (FDA) animal drug user fee agreements, which are set to expire on October 1. Proponents spoke February 27 before the Senate Committee on Health, Education, Labor, and Pensions.
The Animal Drug User Fee Agreement and Animal Generic Drug User Fee Agreement programs mirror the programs for human medical products. The agreements allow the FDA to collect fees from sponsors of animal drug and animal generic drug applications, and the agency uses those fees to help fund review of the applications.
Mitka M. Animal Drug Regulation. JAMA. 2013;309(14):1452. doi:10.1001/jama.2013.2985
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: